Iovance Biotherapeutics Inc. Common Stock vs Viavi Solutions Inc. Common Stock — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.8 (market cap $6.04B), while Viavi Solutions Inc. Common Stock trades at $45.59 (market cap $10.85B). The key difference: Viavi Solutions Inc. Common Stock is the larger of the two by market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, Viavi Solutions Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Viavi Solutions Inc. Common Stock for 1 Days on average.
| IOVA | VIAV | |
|---|---|---|
Market Cap | $6.04B | $10.85B |
Volume | 14,805,993 | 4,281,289 |
Sector | Health | Technology |
52-Week High | $14.82 | $55.33 |
52-Week Low | $1.81 | $12.27 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $5.97B | $10.89B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →Viavi Solutions provides network testing, monitoring, and optical technologies. Its products help communications providers, equipment makers, and enterprises build and maintain networks.
Read more on VIAV →